• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Thursday, June 1, 2023
  • Login
Metro City News
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Finance/Money
  • Sports
  • Others
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Finance/Money
  • Sports
  • Others
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
Metro City News
No Result
View All Result
Home Lifestyle Health & Fitness

AustralaSian COVID-19 Trial opens in India

Metro City News Desk by Metro City News Desk
March 1, 2021
in Health & Fitness, National
Share on FacebookShare on Twitter

New Delhi: AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited last week to the first two sites, Christian Medical College and Hospital Ludhiana in Punjab and Sterling Multispecialty Hospital in Pune, Maharashtra. Australasia is a region that comprises Australia, New Zealand, and some neighboring islands.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.George Institute for Global Health is an independent medical research institute headquartered in Australia with offices in China, India and the United Kingdom.

RelatedPosts

Pure Derma Skincare Brand: Revolutionizing the Industry with Chandresh Ajay Pandey and Akash Gatla

Pure Derma Skincare Brand: Revolutionizing the Industry with Chandresh Ajay Pandey and Akash Gatla

May 31, 2023
Kashiyana Foundation organize 7th Foundation Day at India International Center, Delhi

Kashiyana Foundation organize 7th Foundation Day at India International Center, Delhi

May 29, 2023

ASCOT aims to discover which existing treatments are most effective in patients hospitalised with COVID-19 and whether they will prevent patients deteriorating to the point of needing a ventilator in the Intensive Care Unit.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.

ASCOT Principal Investigator, Associate Professor Steven Tong, a Royal Melbourne Hospital infectious diseases clinician and co-lead of clinical research at the Doherty Institute said that while ASCOT began as an Australian and New Zealand trial, expanding internationally to allow more widespread access to investigational treatments was crucial.

“A key principle of the trial is equity in terms of access to experimental treatments that could potentially have benefits for patients,” Associate Professor Tong said.

“The ASCOT Management Team and Leadership Group recognised early in the course of the trial that for it to have generalisability, external validity and be adequately powered, it would need to be expanded to international sites.”

India, like many other middle and low-income countries, is facing a severe epidemic of COVID-19. The number of patients with COVID-19 in India remains significantly higher than in Australia and New Zealand, and access to experimental treatments is limited.

Bala Venkatesh, Professorial Fellow at the George Institute for Global Health, said that while there are other ongoing clinical trials in India for COVID-19, the novel combinations of treatments included in ASCOT will provide greater opportunities to patients for accessing new treatments.

“We are confident that the study questions being asked are of priority to Indian patients and participating trial sites, and feasible to address in India,” said Professor Venkatesh.

One new treatment that’s recently been added to ASCOT is Nafamostat, which in laboratory experiments has shown to block SARS-COV-2 from entering human cells and be far more potent than Remdesivir.

“Nafamostat is mainly used in Korea and Japan as a treatment for acute pancreatitis and some blood clotting conditions. Of all drugs with potency data from laboratory studies using human cell lines, nafamostat appears to be the most potent against SARS-CoV-2 and maybe the only drug where blood concentrations almost always exceed levels required to stop the virus from replicating,” explained Associate Professor Tong.

“It is also likely that Nafamostat will reach high levels in the lungs where the SARS-CoV-2 virus causes so much of its problems. What’s more, it has a favourable safety profile.”

The ASCOT Steering Committee recently made the decision to cease enrolment into the convalescent plasma arm of the trial following a media release issued by the UK’s RECOVERY trial, which reported no benefit to patients compared with standard of care. (India Science Wire)

Tags: ASCOTAustralaSianChristian Medical College and HospitalClinical TrialCOVID-19Sterling Multispecialty Hospital
ShareTweetShareSendSharePinSend
Previous Post

Dr. Harsh Vardhan dedicates two new databases to the nation

Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Metro City News Desk

Metro City News Desk

Related Posts

Pure Derma Skincare Brand: Revolutionizing the Industry with Chandresh Ajay Pandey and Akash Gatla
Health & Fitness

Pure Derma Skincare Brand: Revolutionizing the Industry with Chandresh Ajay Pandey and Akash Gatla

by Metro City News Desk
May 31, 2023
Kashiyana Foundation organize 7th Foundation Day at India International Center, Delhi
National

Kashiyana Foundation organize 7th Foundation Day at India International Center, Delhi

by Metro City News Desk
May 29, 2023
Medinsider:  A Healthcare online store
Health & Fitness

Medinsider:  A Healthcare online store

by Metro City News Desk
May 25, 2023
SAKRA World Hospital launches the SAKRA Information Centre in Bardhaman, West Bengal
Health & Fitness

SAKRA World Hospital launches the SAKRA Information Centre in Bardhaman, West Bengal

by Metro City News Desk
May 9, 2023
Manzuri Takes Bold Step Against STI Stigma with Free Test Kits and Charitable Partnership
Health & Fitness

Manzuri Takes Bold Step Against STI Stigma with Free Test Kits and Charitable Partnership

by Metro City News Desk
May 1, 2023
Sharp Sight goes above and beyond for employees with ESOP offering
Health & Fitness

Sharp Sight goes above and beyond for employees with ESOP offering

by Metro City News Desk
April 25, 2023
Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Sublethal exposure study of lead (Pb) on black clams to provide early warning information on marine pollution

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Mass Yoga at Pangong Lake gets included in World Book of Records

Mass Yoga at Pangong Lake gets included in World Book of Records

August 2, 2022
International Council of Jurists, London appoints Dr. Kishor Navandar as the President of Asia Chapter for Corporate Division

International Council of Jurists, London appoints Dr. Kishor Navandar as the President of Asia Chapter for Corporate Division

July 1, 2022

How to Pick the Most Comfortable, Spacious Seats on

December 20, 2018

PM Modi to inaugurate IISF 2020

December 21, 2020
Kingston FURY Expands the Look of DDR5 Lineup

Kingston FURY Expands the Look of DDR5 Lineup

May 23, 2023
Child Help Foundation (CHF) volunteered for Odisha and Uttarakhand Flood Relief

Child Help Foundation (CHF) volunteered for Odisha and Uttarakhand Flood Relief

October 28, 2022
Taiwan Product Centre (TPC) aims for USD 25 million sales revenue in India by 2023

Taiwan Product Centre (TPC) aims for USD 25 million sales revenue in India by 2023

December 7, 2021

Film on Padma Shri Kaur Singh’s life finally gets a release date; to be out on July 22

June 27, 2022

Tyre, auto, transport business’ help IPL 2020 Season ride to success

November 3, 2020

Movilti – First Ever Video Review Platform for Cinema

November 1, 2021

Maxworth Realty India Reviews – Common Mistakes to Avoid while buying a house for the First Time

August 12, 2021

CongressNuKaamBoleChe: 2022 on mind, Congress launches ‘Kaam Bolta hai’ campaign in Gujarat

August 18, 2022

Rajat Tiwari – an Indian a wholsome wealth Empire in the Investment Banking

December 6, 2022

The Goenkan Grandeur now a part of The IPL 2020

September 12, 2020

Parvati Nair and Archana Gupta partner with DeSpace to launch their NFT collection

January 28, 2022

Ground work yet to be started at Odisha coal mines

August 10, 2021

Categories

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • Uncategorized
  • World

Recent News

Delhi Times Fashion Week: Blingy Runway Dazzles Fashion World

Delhi Times Fashion Week: Blingy Runway Dazzles Fashion World

June 1, 2023
NM Foods by Tanya: Elevating Your Event with Exquisite Catering

NM Foods by Tanya: Elevating Your Event with Exquisite Catering

June 1, 2023
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

© 2022 Metro City News

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 Metro City News

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In